TELA BIO INC. - COMMON STOCK

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 Dec 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference

19 Nov 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio Reports Third Quarter 2024 Financial Results

07 Nov 2024 15:05:01 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Nov 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

24 Oct 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

23 Oct 2024 07:07:00 By Nasdaq GlobeNewswire

TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

22 Oct 2024 15:05:44 By Nasdaq GlobeNewswire

TELA Bio to Announce Third Quarter 2024 Financial Results

17 Oct 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance

12 Aug 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09 Aug 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference

25 Jul 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio to Announce Second Quarter 2024 Financial Results

22 Jul 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio Appoints Jeffrey Blizard to its Board of Directors

04 Jun 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio Appoints Greg Firestone as Chief Commercial Officer

20 May 2024 15:03:00 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 May 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio Reports First Quarter 2024 Financial Results

09 May 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio to Announce First Quarter 2024 Financial Results

25 Apr 2024 06:00:00 By Nasdaq GlobeNewswire

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures

15 Apr 2024 06:00:00 By Nasdaq GlobeNewswire

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy

08 Apr 2024 06:00:00 By Nasdaq GlobeNewswire

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

21 Mar 2024 15:05:00 By Nasdaq GlobeNewswire